GCP
CLOV icon

Gill Capital Partners’s Clover Health Investments CLOV Stock Holding History

Gill Capital Partners’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$88 Buy
+50
New +$108 ﹤0.01% 678

Other funds holding CLOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gill Capital Partners's CLOV Position: Q1 2026 in Review

Gill Capital Partners opened a new position in Clover Health Investments (CLOV) in Q1 2026: 50 shares worth $88. The stake represents ﹤0.01% of the portfolio and ranks #678 among its holdings.

208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Gill Capital Partners held 50 shares of Clover Health Investments worth $88 as of Q1 2026.
  • Clover Health Investments was a new Gill Capital Partners position in Q1 2026.
  • Clover Health Investments made up ﹤0.01% of Gill Capital Partners's portfolio in Q1 2026, its #678 holding.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Gill Capital Partners's 13F filing for Q1 2026, filed 13 Apr 2026.